Chloromethyl Isopropyl Carbonate Market Size will reach to 7,017 mt in 2024
Chloromethyl Isopropyl Carbonate (CMIC) is the key intermediate of tenofovir which is a anti-AIDS and anti-hepatitis B drug developed by Gilead Sciences. It is colorless and transparent liquid at room temperature. The CAS Registry Number of CMIC is 35180-01-9.
The key raw material of CMIC is methyl chloroformate, dimethylaniline and isopropyl alcohol. Then CMIC can be used to produce tenofovir API. Following are the simple manufacturing process from CMIC to tenofovir:
There are 7 CMIC producers covered in the report: Huangshi Fuertai, Inner Mongolia Saintchem, Chemcon Speciality Chemicals Ltd., Shanghai Twisun, Paushak, Atul, Anshul Specialty. These producers locate at India and China. China is the largest production country and install about 67% production capacity in 2018. India is smaller than China and install about 33% capacity in 2018. China and India is also the tenofovir API production base. The tenofovir API production in India and China include Aurobindo Pharma Ltd., Bharat Pharmaceuticals, HEC PHARM CO., Ltd., Zhejiang Supor Pharmaceuticals Co., Ltd., Taizhou Volsen Chemical CO., Ltd., Strides Shasun Ltd., SMS Pharmaceuticals Ltd., Sichuan Jiangchuan Pharmaceutical Co.,Ltd., Shanghai Acebright Pharmaceuticals Group Co., Ltd., Orbit Lifescience Pvt. Ltd., Macleods Pharmaceuticals Ltd., Laurus Labs Private Ltd., GIHI Chemicals CO. Ltd., Cipla Ltd., Aurisco Pharmaceutical Ltd., Anhui Biochem United Pharmaceutical Co., Ltd. and Acebright (India) Pharma Private Limited. India and China consume about 80% CMIC in 2018.
Global tenofovir and its combination preparations market size is about 14 billion USD in 2018. It is the largest anti-AIDS drug around the world. Global chloromethyl isopropyl carbonate (CMIC) market size was estimated at 3,855 mt in 2018 and the market size will reach 7,017 mt in 2024, with a CAGR of 10.5% due to strong demand of tenofovir.
